COL5A2 and cancer: Besides VEGFA which was widely known and applied in anti-angiogenic therapy, in our pan-cancer analysis, some genes, like SPP1, STC1 and COL5A2, were not only highly expressed in most tumors, but also risk factors of prognosis.